IFF and Kemira announced the formation of Alpha Bio, a 50/50 joint venture focused on the commercial-scale production of renewable biobased materials. The venture involves an investment of approximately €130 million.
The Alpha Bio facility, located in Kotka, Finland, is slated to start production in late 2027. It will convert up to 44,000 metric tons of plant sugars annually into bioproducts, including high-performance biopolymers for home and personal care and industrial solutions.
This partnership leverages IFF’s proprietary Designed Enzymatic Biomaterial™ (DEB) platform technology, which uses plant-based sugars and enzymes to create sustainable alternatives to fossil-based polymers. The initiative is expected to generate approximately 30 direct new jobs in the Kotka area.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.